![TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection](https://www.spandidos-publications.com/article_images/mmr/17/1/MMR-17-01-0243-g01.jpg)
TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection
![Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers - ScienceDirect Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0198885917305104-fx1.jpg)
Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers - ScienceDirect
![CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00410-6/MediaObjects/13578_2020_410_Fig1_HTML.png)
CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text
![CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy](https://www.cell.com/cms/attachment/934234ac-310f-48a1-9862-132cc3e99ecc/fx1_lrg.jpg)